Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.
News Medical Dermatology News Feed
Study identifies C5aR1 as a key marker of metastasis in skin cancer
